Latest news
The BioPharm Brief: Targets, Technology, and Timing - BioPharm InternationalBioPharm International · Mon, 10 Aug 2026 19:51:10 GMTWhy Talent and Market Access Should Drive Biotech Location Decisions - BioPharm InternationalBioPharm International · Thu, 06 Aug 2026 23:57:23 GMTFDA Accepts Merck's Application to Expand Enflonsia into Second RSV Season - BioPharm InternationalBioPharm International · Thu, 06 Aug 2026 16:59:38 GMTModerna's mFLUSIVA Approval Validates mRNA Platform Beyond COVID-19: What It Means for Biopharmaceutical Manufacturing - BioPharm InternationalBioPharm International · Thu, 06 Aug 2026 16:59:36 GMTThe Evolving Bioconjugate Landscape - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 07:00:00 GMTNavigating Biopharma Complexity: Why Long-Term Partnerships Matter - BioPharm InternationalBioPharm International · Tue, 04 Aug 2026 10:28:23 GMT